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ABSTRACT
This study aimed to explore how medical students differ regarding the HPV vaccination 
status according to their demographics, sexuality, medical school year and sources of 
information regarding the vaccine. The cross-sectional survey included 379 participants 
from medical school year 1 to 6, in a medical school in Brasilia. Statistical analyses of 
the data obtained from a questionnaire analyzed contingency tables and highlighted odds 
ratios effect sizes. The results showed that among all the participants, 80 (21.1%) were 
vaccinated against HPV, 215 (58.7%) were not vaccinated but wanted to be and 84 (22.2%) 
were neither vaccinated nor wanted to be vaccinated. . Female gender (OR= 5.88, 95% 
CI 3.36-10.30), parental advice (OR= 6.95, 95% CI= 3.97-12.16), and absence of sexual 
initiation before 16 years of age (OR= 3.04, 95% CI= 1.05-8.77) were positively associated 
with HPV-vaccinated students. In parallel, female gender (OR= 4.74, 95% CI= 2.38-9.44), 
parental advice (OR= 3.50, 95% CI=1.20-10.22), and reporting two or more recent sexual 
partners (OR= 2.03, 95% CI= 1.06-3.88) were positively associated with the intention to 
be vaccinated among unvaccinated students. The high cost of the vaccine was perceived 
as a barrier among those respondents who wished to be vaccinated. Additionally, among 
the 84 (81.3% male) students who admitted unwillingness to be vaccinated, approximately 
two-thirds cited the feeling to be safe, lack of counseling, or low efficacy of the vaccine as 
the reasons for their reluctance. In conclusion, vaccination coverage was low among these 
medical students. Nevertheless, female gender, personal advice, and safe sex were the main 
factors associated with higher levels of vaccination and vaccine acceptance. 
KEYWORDS: Medical students. Papillomavirus vaccination. Sexual behavior. Surveys and 
questionnaires. Cross-sectional study.
INTRODUCTION
Human papillomavirus (HPV) is the most prevalent viral infection of the 
reproductive tract. HPV is the causal agent of a variety of conditions in both men 
and women, some of which may progress to cancer. Persistent HPV infection may 
result in disease, although acute infections may resolve spontaneously without 
symptoms or treatment1. In women, persistent infection with HPV-16 and HPV-18 
genotypes (among others) can lead to premalignant lesions that may progress to 
cervical cancer if left untreated2. Moreover, HPV infection is also a causal agent 
of the majority of oropharyngeal and anogenital cancers and other diseases in both 
genders3.
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The United Kingdom introduced a nationwide HPV 
immunization program in 20084. In Brazil, the use of the 
quadrivalent vaccine in the national vaccination program 
started in 2014 and initially targeted girls aged 9-13 years 
old with a three-dose schedule5. Since 2017, the HPV 
vaccine became available in the public health system for 
females aged 9-14 years old and males aged 11-14 years 
old in a two-dose schedule5. The efficacy and safety of the 
quadrivalent vaccine has been reaffirmed by the World 
Health Organization experts6.
Evaluating the vaccination status and perceptions of 
medical students is crucial as their attitudes as future 
health providers could influence their patients’ adherence 
to vaccination programs against HPV. Most relevant 
studies have focused on the knowledge and beliefs of 
the participants regarding the vaccine and its use, with 
no information on vaccination rates7. Nevertheless, 
a study in Scotland revealed a sharp increase in the 
vaccination rates of female medical students within a 
year after the beginning of the national immunization 
program4. Moreover, a survey from the United States 
found a 44% vaccination rate among medical school 
students, and the authors asserted the positive role of 
provider’s recommendations8. Additionally, a Brazilian 
study evaluated the level of knowledge and use of the 
vaccine among medical (and literature) students. The 
authors highlighted the low vaccination coverage among 
the students and sex differences in the vaccination rate, 
familiarity with, and interest in being vaccinated9.
As a further contribution to the topic, the current study 
aimed to explore how medical students differ regarding 
HPV vaccination status according to their demographics, 
sexuality, medical school year, and sources of information 
regarding the vaccine. We used a survey questionnaire to 
pursue the following research questions:
a)  does the students’ vaccination status relate to their 
demographics (age, sex, and family income) and level 
of medical studies?
b)  are the students’ responses about personal or media 
sources of information regarding the HPV vaccine 
related to their vaccination status?
c)  do students who report early sexual intercourse or 
multiple sexual partners have a lower rate of HPV 
vaccination? 
METHODS
This study was a cross-sectional survey on a population 
of undergraduate students from the first to the sixth year of 
the Faculty of Medicine, University of Brasilia, a federal 
public university. We based the sample size calculation on 
the total of 521 students who were enrolled in for courses 
and activities in 2017. The sample size needed for a 
satisfactory response rate was 350 students (95% confidence 
level, 3% confidence interval). 
The Ethics Committee on Research in Human Beings 
of the Faculty of Medicine (1.989.835) approved the study.
In the second semester of 2017, during classes, the 
survey questionnaires that were created based on a literature 
review7,10-12 were applied by four authors of the study, and 
392 students returned the questionnaires. Thirteen cases 
were excluded from the study (six because the respondents 
omitted information about HPV vaccination and seven 
because they were younger than 18 years old). Thus, the 
analyses included 379 questionnaires. 
Categorical data were reported as counts and frequencies. 
These data were checked using contingency analyses, which 
applied the qui-square test that highlighted the magnitude 
of odds ratios (ORs), 95% confidence intervals (CIs), or 
and the Fisher’s exact tests. The analyses were carried out 
with the SPSS software, version 17 (IBM, New York, USA). 
The respondents were grouped for statistical purposes, as 
shown in Table 1.
RESULTS
Students’ profiles
The mean age of the 379 participants was 21.8± 3.1 
years (SD), and 81 (21.6%) students were older than 
23 years. Only 161 participants (42.5%) were female. 
Regarding the level of medical studies, 134 (35.4%) were 
in their 1st or 2nd year, 137 (36.1%) were in their 3rd or 4th 
year, and 108 (28.5%) were in their 5th or the 6th year of the 
medical school. Concerning the family income, 279 (75.8%) 
reported earnings of five or more Brazilian minimum wages. 
Among the 372 respondents, 97 (26.1%) were celibate, 93 
Table 1 - Grouping of respondents for statistical purposes.
Attribute Groups
Age range < 24 years; 24 years or older.
Family income < Five times the minimum wage; five times the minimum wage or more. 
Sexual initiation Before 16 years of age; later or none. 
Sexual partners None; one; two or more (per year).
Vaccination 
status
Vaccinated; not vaccinated but willing to be 





None; personal (parent, friend, doctor, 
or health professional); media (internet, 
printed material, television or government 
campaigns).
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(25%) had an average of two or more sexual partners per 
year, and 44 (11.7%) reported the first sexual intercourse 
under the age of 16. Additionally, 76% of the sexually active 
students reported the use of barrier contraceptive methods. 
Furthermore, the vast majority (93.7%) of the participants 
were aware of the public availability of the HPV vaccine, 
but less than half (48.9%) knew that it was available to 
both genders. 
HPV vaccination contingencies
Among all the participants, 80 (21.1%) were vaccinated 
against HPV, 215 (58.7%) were not vaccinated but desired 
to be and 84 (22.2%) were neither vaccinated nor wanted to 
be vaccinated. The students’ distribution among these three 
vaccination categories was significantly associated with sex 
(Cramer’s V= .412, p< .001), reported source of information 
(media, personal, or a mix) about the vaccine (Cramer’s 
V= .276, p< .001), and age bracket (Cramer’s V= .139, 
p= .026) but not with the level of medical studies (Cramer’s 
V= .100, p= .149). Notably, older students (≥ 24 years of 
age), in comparison with younger participants, had a lower 
percentage of vaccination (13.4 vs. 23.2%) and a higher 
percentage of individuals who avoided vaccination (31.7 
vs. 19.5%). Table 2 shows that the majority of vaccinated 
students reported having a personal source of information 
only.
Comparing the rates of vaccination among the participants, 
the vaccine acceptance was positively and significantly 
associated with parental advice (52.0 vs. 13.5%; phi= .376, 
p< .001), female sex (37.3 vs. 9.2%; phi = .340, p< .001), and 
delayed or no sexual initiation (23.3 vs. 9.1%; phi= .112, p= 
.031). In contrast, vaccination was not significantly associated 
with younger age (phi= .099, p= .054), higher level of medical 
studies (phi= -.040, p= .435), single partner, celibate status 
(phi= -.030, p= .560), or higher family income (phi= .013, 
p= .790). Notably, except for parental advice, no other source 
of information (personal or media) showed a significant 
positive association with vaccination. Table 3 highlights the 
differential ORs of the associations (regarding vaccination) 
with parental advice, female sex, early sexual initiation and 
younger age.
Comparing proportions of students willing or not to be 
vaccinated, significant positive associations were found 
for female sex (89.1 vs. 63.1%; phi= .273, p< .0001) and 
parental advice (88.9 vs. 69.6%; phi= .140, p= .0167), 
Table 2 - Medical students’ vaccine status and sources of information about the HPV vaccine.
Information sources
Students’ vaccine status
Not vaccinated  
not willing to (n, %)
Not vaccinated  





None 6 (46.2) 6 (46.2) 6 (7.7) 13 (3.4)
Media only (A) 51 (30.2) 102 (60.4) 16 (9.5) 169 (44.6)
Mix (A & B) 10 (13.0) 54 (70.1) 13 (16.9) 77 (20.3)
Personal only (B) 17 (14.2) 53 (44.2) 50 (41.7) 120 (31.7)
Total 84 (22.2) 215 (56.7) 80 (21.1) 379 (100)
A) printed material, Internet, TV or government campaign; B) parent, friend, doctor or health professional. Measure of association: 
Cramer’s V; value: 0.276, p < .001
Table 3 - HPV vaccination status among medical students grouped according to four categories of retrospective influence on 
vaccine use (N= 379). 
Categories Groups
Vaccination Odds ratio Fisher’s 










< 16 years 40 4
.33 .11-.95 .0317
Later or none 250 76
Age range 
<24 years old 228 69
1.95 .98-3.89 .0659
≥24 years old 71 11
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while a negative association was found for single partner/
celibate status (68.2 vs. 81.3%; phi= -.127, p= .0371). In 
contrast, no significant associations were found between 
willing to be vaccinated and younger age (74.6 vs. 63.4%; 
phi= .106, p= .071), higher level of medical studies (64.8 
vs. 74.9%; phi= .102, p= .090), sexual initiation before 16 
years old (70.0 vs. 71.8%; phi= -.0102, p= .851), or higher 
family income (73.1 vs. 71.8%; phi= .012, p= .878). Table 4 
highlights the decreasing odds ratios (posture regarding 
vaccination) for female sex, parental advice, multiple 
partners and younger age.
Among the 299 unvaccinated students, those willing 
to be vaccinated (41.9% females) also differed from those 
who did not want to be vaccinated (86.9% males), both 
in the relative frequency and the willingness to report the 
reasons for their reluctance. Only 58.6% of the students 
gave a reason in the first group (those who wanted to be 
vaccinated), in comparison with 89.3% who gave a reason 
in the second group. Out of ten listed reasons, the following 
four were selected by at least 10% of respondents from one 
of the groups: excessive cost of the vaccine, not being advised 
about vaccination, feeling safe from the infection, and the low 
efficacy of the vaccine. Table 5 highlights the differences in 
the frequencies between the two groups for the seven most 
cited reasons not to be vaccinated against HPV. 
DISCUSSION
This study carried out with undergraduate medical 
students shows significant differences in the HPV 
vaccination status according to sex, sexual behavior and 
source of information about the vaccine. The vaccination 
rates among female medical students in Brasilia and Rio de 
Janeiro were comparable, but they were much lower than 
those found in Glasgow or Rochester4,8,9. One reason for 
the lower vaccination rate is the recent start (2014)5 of the 
national program of immunization against HPV in Brazil, 
in comparison with the initiation of the UK (2008)4 or the 
US (2006)8 HPV vaccination. Less emphasis on women’s 
reproductive health could be another reason.
The male vaccination rate was one-fourth of the female 
rate. In addition to the so-called vaccine feminization13, 
ascribed to the initial implementation strategy of the HPV 
vaccination, the male students may feel more protected 
from HPV infections, as suggested by one of the motives 
of unwillingness to be vaccinated and the prevalent use of 
sexual preservatives among the sexually active participants. 
Research carried out with university students in Turkey, Iran 
and India showed that 21.7%, 56% and 80% of students, 
respectively, shared the idea that condoms provide a total 
protection against HPV10,14,15 infections, inducing the belief 
that the use of sexual preservatives would eliminate the 
need for vaccination.
There was also no significant difference in the 
vaccination status among income groups, even though more 
than one-fourth of the unvaccinated students marked the 
high cost of the vaccine as a reason not to get vaccinated. 
Table 4 - Desire of HPV vaccination status among medical students grouped according to four categories ordered by decreasing 
odds of a relationship (N=299). 
Categories Groups
Wants vaccine Odds ratio Fisher’s 










Two or more 14 61
2.03 1.06-3.88 .0371
One or none 69 148
Age range 
<24 years old 58 170
1.69 .96-2.99 .0715
≥24 years old 26 45
Table 5 - Differences in reasons for avoiding HPV vaccination 
between students who want or not the vaccine (N= 299). 
Reason cited for reluctance
Want Not want 
n (%) n (%)
The high cost of the vaccine 55 (25.6) 9 (10.7)
Not advised about vaccination 25 (11.6) 19 (22.5)
Doubt about vaccine effects 18 (8.4) 3 (3.6)
Feeling safe from infection 14 (6.5) 20 (23.8)
Low efficacy of vaccination 10 (4.6) 13 (15.5)
Other reasons 4 (1.9) 11 (13.1)
No reason cited 89 (41.4) 9 (10.7)
Measure of association: Cramer’s V= .487, p < .0001.
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The economic barrier is a reality in a country that provides 
the vaccine free of charge only for the primary school 
age group5. Most respondents were out of the target age 
group when the national immunization program started 
in 2014 and therefore would have to bear the cost of 
vaccination that is about one-third of the minimum wage 
for each dose. In addition to that barrier, other reasons (and 
underlying factors) may contribute not to get vaccinated, 
as suggested by the data shown in Table 5. It is noteworthy 
that one of these reasons was ‘not being counseled about 
the vaccination’, which was reported by one-fifth of the 
participants who did not want the vaccine.
An interesting finding was the dual role of the student’s 
sexual behavior. Starting sexual intercourse before 16 years 
of age was negatively associated with vaccination. In 
contrast, among the unvaccinated respondents, the desire 
to be vaccinated was positively associated with two or 
more recent sexual partners. In either case, we suggest that 
a precautionary approach may support both associations. 
On the other hand, a study of American youth aged 15-24 
years old showed that those who were sexually active had 
twice the intention of receiving the HPV vaccine when 
compared to the intentions of women who were not yet 
sexually active16. Additionally, a Spanish study showed that 
the prevalence of sexual risky behaviors was high in non-
vaccinated university women and was primarily related to 
the non condom use. This finding contradicts the idea that 
vaccinated women could increase their sexual risks because 
of the protection ascribed to vaccination17.
Another interesting result was the strong relationship 
between either vaccination or the will to be vaccinated 
and parental advice about the vaccine. While knowledge 
acquisition was more common through the internet, the 
press, and government programs, vaccination advice was 
more effective when provided by parents. Although not 
surprising, this finding contrasts with the usual emphasis 
on the role of the health provider7. For example, a study 
reported that the vaccination rate is higher when the provider 
makes consistent recommendations and emphasizes 
cancer prevention18. However, a study in India showed 
that most doctors not only felt uncomfortable discussing 
the reproductive lives of girls with the parents of these 
adolescents but also believed that their patients would 
ignore a recommendation for vaccination19. We suggest that 
the planning of HPV vaccination campaigns place more 
importance on providing advice to the parents of boys and 
girls while reinforcing the role of well-prepared physicians 
and other health care providers.
As expected, older students (≥24 years of age), in 
comparison with younger participants, had a lower 
percentage of vaccination and a higher percentage of vaccine 
avoidance. Older students may feel less conviction about 
the practicality of vaccination for themselves, perhaps due 
to a longer sexual life. Whatever the reasons, vaccination 
avoidance is detrimental because of the current evidence 
of the quadrivalent HPV vaccine efficacy and safety for 
both, young women20 and men21. One could consider the 
young adulthood as the final moment for the prevention of 
HPV-related-cancer. 
Furthermore, among the participants in this study, the 
vaccination status was not significantly related to the level of 
medical training, which was similar to the findings of other 
authors9,22 that a higher level of knowledge did not reflect in 
higher vaccination rates. On the other hand, Afonso et al.8 
observed that students who received all doses of the vaccine 
had higher university grades than unvaccinated students. 
Finally, the high likelihood of lifetime HPV makes 
vaccination of young adults, including college students, 
imperative23. This issue points to the need for improved 
vaccine communication training for students in health-
related professions, as discussed in the recent systematic 
literature review23.The multifaceted approach described 
by Schnaith et al.24 seems feasible and interesting. This 
approach includes a mix of information, demonstration, 
and role plays in students’ curriculum to prepare them for 
communicating the HPV vaccine. 
The study has some limitations. The cross-sectional 
design makes causal explanations difficult and a single 
medical school approach limits the generalization of results. 
Furthermore, the accuracy of self-reported data is uncertain. 
However, the satisfactory response rate supports the internal 
validity of the results, that are compatible with the current 
understanding of the problems. 
In conclusion, this study confirms the low vaccination 
coverage among Brazilian medical students from a single 
federal university and affirms the male disparity in vaccine 
use. The findings emphasize the consistent association of 
female sex and parental advice with HPV vaccination. The 
results also indicate the role that sexual behavior factors play 
in vaccination status and suggest a preventive perspective as 
a significant predictor of vaccine use, even if it was observed 
in only a minority of the student body. 
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